Quince Therapeutics
QNCX
#9113
Rank
C$0.11 B
Marketcap
$2.56
Share price
1.14%
Change (1 day)
71.07%
Change (1 year)

EPS for Quince Therapeutics (QNCX)

EPS in 2023 (TTM): -$1.12

According to Quince Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.19. In 2022 the company made an earnings per share (EPS) of -$2.27 an increase over its 2021 EPS that were of -$4.36.

EPS history for Quince Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.12-50.65%
2022-$2.27-47.85%
2021-$4.3615.21%
2020-$3.7962.51%
2019-$2.33179.56%
2018-$0.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.14 162.65%๐Ÿ‡บ๐Ÿ‡ธ USA